Skip to main content

Ophthalmology's Shigemi Matsuyama explains team's research to test a possible oral medication for retinitis pigmentosa

MEDIA | July 31, 2024
STORY BY: EDITORIAL STAFF

CWRU tests treatment to prevent blindness caused by inherited eye disease, and other brain diseases

cleveland.comShigemi Matsuyama, an associate professor of ophthalmology and visual sciences, explained his team’s research behind a $1.5 million grant from the Foundation Fighting Blindness to test a possible oral medication for the genetic eye disease retinitis pigmentosa.